Market Research Logo

North America Stem Cell Market Forecast 2018-2026

North America Stem Cell Market Forecast 2018-2026

KEY FINDINGS

The North America Stem cell market is estimated to grow at a CAGR of 9.66% during the forecast period of 2018-2026. The government’s subsidy and sustenance in the field of stem cell market, increasing investments in R&D and surge in neurodegenerative ailments are some of the factors driving the stem cell market.

MARKET INSIGHTS

Stem cell market is segmented by products, by technology, and by applications. The United States and Canada are the two key countries in the North American market. The United States has captured a significant share of North America’s stem cell market, and it is expected to be the fastest-growing market in the region. The rise in the number of cancer cases is significantly driving this market’s growth. The United States is well known for its advanced healthcare infrastructure. However, stringent government regulations are hampering the market growth.

COMPETITIVE INSIGHTS

Companies like Stemedica Cell Technologies Inc, Cytori Therapeutics, Biotime Inc, Thermo Fisher Vericel Corporation (Formerly Aastrom Bioscience), Ge Healthcare, Becton Dickinson, Celgene Corporation, Cellular Dynamics International (Holding Company Fujifilm), Fibrocell Science Inc, Brainstorm Cell Therapeutics, Takara Holdings Inc., and Kangstem Biotech Ltd are operating in this region.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Regenerative Medicine Is The Emerging Branch Of Medical Science
3.2.2. Use Of Adult Stem Cells Has Been Significant
4. Market Determinants
4.1. Market Driver
4.1.1. Potential Of Stem Cells In Regenerative Medicine
4.1.2. Key To Anti-ageing And Prolonging Life
4.1.3. Increasing R&D Investments In Adult Stem Cell Research
4.1.4. Ease Of Administration
4.1.5. Reduced Risk Of Tissue Rejection In Transplants
4.1.6. Federal Funding For Stem Cell Research
4.2. Market Restraints
4.2.1. Safety Issues
4.2.2. Ethical Issues
4.3. Opportunities
4.3.1. Technological Innovations
4.3.2. Emerging Application As A Drug Discovery Tool
4.3.3. Other Promising Applications
4.4. Market Challenges
4.4.1. Stringent Government Regulations
5. Market Segmentation
5.1. Market By Products 2018-2026
5.1.1. Adult Stem Cell Market
5.1.1.1. Hematopoietic Stem Cell Market
5.1.1.2. Mesenchymal Stem Cell Market
5.1.1.3. Neural Stem Cell Market
5.1.1.4. Dental Stem Cell Market
5.1.1.5. Umbilical Cord Stem Cell Market
5.1.2. Human Embryonic Stem Cell
5.1.3. Induced Pluripotent Stem Cell Market
5.1.4. Rat Neural Stem Cell Market
5.2. Market By Technology 2018-2026
5.2.1. Stem Cell Acquisition
5.2.1.1. Stem Cell Bone Marrow Market
5.2.1.2. Stem Cell Apheresis Market
5.2.1.3. Umbilical Cord Blood Market
5.2.2. Stem Cell Production
5.2.2.1. Therapeutic Cloning
5.2.2.2. Ivf Stem Cell
5.2.2.3. Stem Cell Culture
5.2.3. Stem Cell Cryopreservation
5.2.4. Stem Cells Expansion And Sub-culture
5.3. Market By Application 2018-2026
5.3.1. Regenerative Medicine
5.3.2. Drug Discovery And Development
6. Key Analytics
6.1. Porter’s Five Forces Analysis
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute Products Or Services
6.1.3. Bargaining Power Of Buyer
6.1.4. Bargaining Power Of Supplier
6.1.5. Intensity Of Competitive Rivalry
6.2. Value Chain Analysis
6.3. Opportunity Matrix
6.4. Key Buying Criteria
6.4.1. High Price
6.4.2. Efficacy
6.4.3. Application And Effectiveness
6.4.4. Accuracy
6.5. Pest Analysis
6.6. History Of Stem Cell
6.7. Patent Analysis
6.7.1. Stem Cell Patent In North America
6.8. Regulatory Framework
7. Geographical Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
8. Company Profile
8.1. Competitive Landscape
8.1.1. Market Share Analysis
8.2. Becton Dickinson
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Biotime Inc
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Brainstorm Cell Therapeutics
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.4.4. Strategic Initiatives
8.5. Celgene Corporation
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Cellular Dynamics International (Holding Company Fujifilm)
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.6.4. Strategic Initiatives
8.7. Cellular Engineering Technologies Inc.
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Corestem Inc
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. Corning Inc.
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Cytori Therapeutics
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Fibrocell Science Inc
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Scot Analysis
8.11.4. Strategic Initiatives
8.12. Ge Healthcare
8.12.1. Company Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Kangstem Biotech Ltd
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Strategic Initiatives
8.14. Stemedica Cell Technologies Inc
8.14.1. Company Overview
8.14.2. Product Portfolio
8.14.3. Strategic Initiatives
8.15. Stryker Corporation
8.15.1. Company Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives
8.16. Takara Holdings Inc.
8.16.1. Company Overview
8.16.2. Product Portfolio
8.16.3. Scot Analysis
8.16.4. Strategic Initiatives
8.17. Thermo Fisher
8.17.1. Company Overview
8.17.2. Product Portfolio
8.17.3. Scot Analysis
8.17.4. Strategic Initiatives
8.18. Vericel Corporation (Formerly Aastrom Bioscience)
8.18.1. Company Overview
8.18.2. Product Portfolio
8.18.3. Scot Analysis
8.18.4. Strategic Initiatives
Table List
Table 1 North America Stem Cell Market 2018-2026 ($ Million)
Table 2 North America Stem Cells Market By Products 2018-2026 ($ Million)
Table 3 North America Stem Cell Market In Adult Stem Cell 2018-2026 ($ Million)
Table 4 North America Stem Cell Market In Adult Stem Cell By Types 2018-2026 ($ Million)
Table 5 North America Adult Stem Cell Market In Hematopoietic Stem Cell 2018-2026 ($ Million)
Table 6 North America Adult Stem Cell Market In Mesenchymal Stem Cell 2018-2026 ($ Million)
Table 7 North America Adult Stem Cell Market In Neural Stem Cell 2018-2026 ($ Million)
Table 8 North America Adult Stem Cell Market In Dental Stem Cell 2018-2026 ($ Million)
Table 9 North America Adult Stem Cell Market In Umbilical Cord Stem Cell 2018-2026 ($ Million)
Table 10 North America Stem Cell Market In Human Embryonic Stem Cell 2018-2026 ($ Million)
Table 11 North America Stem Cells Market In Induced Pluripotent Stem Cell 2018-2026 ($ Million)
Table 12 North America Stem Cell Market In Rat Neural Stem Cell 2018-2026 ($ Million)
Table 13 North America Stem Cell Market By Technology 2018-2026 ($ Million)
Table 14 North America Stem Cell Market In Acquisition By Types 2018-2026 ($ Million)
Table 15 North America Stem Cell Market In Acquisition 2018-2026 ($ Million)
Table 16 North America Stem Cell Acquisition Market In Bone Marrow By Geography 2018-2026 ($ Million)
Table 17 North America Stem Cell Acquisition Market In Cell Apheresis 2018-2026 ($ Million)
Table 18 North America Stem Cell Acquisition Market In Umbilical Cord Blood 2018-2026 ($ Million)
Table 19 North America Stem Cell Market In Production By Types 2018-2026 ($ Million)
Table 20 North America Stem Cell Market In Production 2018-2026 ($ Million)
Table 21 North America Stem Cell Production Market In Therapeutic Cloning 2018-2026 ($ Million)
Table 22 North America Stem Cell Production Market In Ivf Stem Cell 2018-2026 ($ Million)
Table 23 North America Stem Cell Production Market In Stem Cell Culture 2018-2026 ($ Million)
Table 24 North America Stem Cell Market In Stem Cell Cryopreservation 2018-2026 ($ Million)
Table 25 North America Stem Cell Market In Stem Cell Expansion And Sub-culture 2018-2026 ($ Million)
Table 26 North America Stem Cells Market By Application 2018-2026 ($ Million)
Table 27 North America Stem Cells Market In Regenerative Medicine 2018-2026 ($ Million)
Table 28 North America Stem Cell Market In Drug Discovery And Development 2018-2026 ($ Million)
Table 29 North America Stem Cell Market, By Country, 2018-2026 (In $ Million)
Figures List
Figure 1 North America Stem Cell Market 2018-2026 ($ Million)
Figure 2 North America Stem Cell Market In Adult Stem Cell 2018-2026 ($ Million)
Figure 3 North America Adult Stem Cell Market In Hematopoietic Stem Cell 2018-2026 ($ Million)
Figure 4 North America Adult Stem Cell Market In Mesenchymal Stem Cell 2018-2026 ($ Million)
Figure 5 North America Adult Stem Cell Market In Neural Stem Cell 2018-2026 ($ Million)
Figure 6 North America Adult Stem Cell Market In Dental Stem Cell 2018-2026 ($ Million)
Figure 7 North America Adult Stem Cell Market In Umbilical Cord Stem Cell 2018-2026 ($ Million)
Figure 8 North America Stem Cell Market In Human Embryonic Stem Cell 2018-2026 ($ Million)
Figure 9 North America Stem Cells Market In Induced Pluripotent Stem Cell 2018-2026 ($ Million)
Figure 10 North America Stem Cell Market In Rat Neural Stem Cell 2018-2026 ($ Million)
Figure 11 North America Stem Cell Market In Acquisition 2018-2026 ($ Million)
Figure 12 North America Stem Cell Acquisition Market In Bone Marrow 2018-2026 ($ Million)
Figure 13 North America Stem Cell Acquisition Market In Apheresis 2018-2026 ($ Million)
Figure 14 North America Stem Cell Acquisition Market In Umbilical Cord Blood 2018-2026 ($ Million)
Figure 15 North America Stem Cell Market In Production 2018-2026 ($ Million)
Figure 16 North America Stem Cell Production Market In Therapeutic Cloning 2018-2026 ($ Million)
Figure 17 North America Stem Cell Production Market In Ivf Stem Cell 2018-2026 ($ Million)
Figure 18 North America Stem Cell Production Market In Stem Cells Culture 2018-2026 ($ Million)
Figure 19 North America Stem Cell Market In Stem Cells Cryopreservation 2018-2026 ($ Million)
Figure 20 North America Stem Cell Market In Stem Cell Expansion And Sub-culture 2018-2026 ($ Million)
Figure 21 North America Stem Cells Market In Regenerative Medicine 2018-2026 ($ Million)
Figure 22 North America Stem Cell Market In Drug Discovery And Development 2018-2026 ($ Million)
Figure 23 The United States Stem Cell Market 2018-2026 (In $ Million)
Figure 24 Canada Stem Cell Market 2018-2026 (In $ Million)
Figure 25 Stem Cell Market Share Analysis Of Key Players 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report